Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome

Modern Rheumatology

Volumn 21, Issue 1, 2011, Pages 92-96

  Kobayashi, Masafumi ^a   Takahashi, Yuko ^a   Yamashita, Hiroyuki ^a   Kaneko, Hiroshi ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Adult onset Still's disease; Hemophagocytic lymphohistiocytosis; Macrophage activation syndrome; Tocilizumab

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CEFTRIAXONE; CYCLOSPORIN; DEXAMETHASONE; FERRITIN; LOW MOLECULAR WEIGHT HEPARIN; PIPERACILLIN; PREDNISOLONE; TOCILIZUMAB; TOSUFLOXACIN TOSILATE;

ADD ON THERAPY; ADULT; ADULT ONSET STILL DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BONE MARROW BIOPSY; CASE REPORT; CLOSTRIDIUM INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FERRITIN BLOOD LEVEL; FEVER; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOSIS; LYMPHADENOPATHY; MACROPHAGE ACTIVATION SYNDROME; MAINTENANCE THERAPY; POLYARTHRITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RASH; RISK BENEFIT ANALYSIS; SORE THROAT; THROMBOCYTOPENIA; VIREMIA;

ANTIBODIES, MONOCLONAL; CYCLOSPORINE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPOSOMES; MACROPHAGE ACTIVATION SYNDROME; MIDDLE AGED; RISK ASSESSMENT; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 79951948588     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0348-9     Document Type: Article

References (35)

1. S Pay N Türkçapar M Kalyoncu I Simşek E Beyan I Ertenli MA Oztürk N Düzgün H Erdem Z Ozbalkan S Kiraz G Kinikli N Besbas A Dinç A Ateş U Olmez M Calgüneri OT Aydintuǧ A Bakkaloǧlu M Turan M Turgay Y Karaaslan R Topaloǧlu M Duman S Ozen 2006 A multicenter study of patients with adult-onset Still's disease compared with systemic juvenile idiopathic arthritis Clin Rheumatol 25 639 644 10.1007/s10067-005-0138-5 16365690 (Pubitemid 44111303)
2. EG Bywaters 1971 Still's disease in the adult Ann Rheum Dis 30 121 133 1:STN:280:DyaE3M3os1SksA%3D%3D 10.1136/ard.30.2.121 5315135
3. M Yamaguchi A Ohta T Tsunematsu R Kasukawa Y Mizushima H Kashiwagi S Kashiwazaki K Tanimoto Y Matsumoto T Ota 1992 Preliminary criteria for classification of adult Still's disease J Rheumatol 19 424 430 1:STN:280:DyaK383ltFOlsw%3D%3D 1578458
4. P Efthimiou S Georgy 2006 Pathogenesis and management of adult-onset Still's disease Semin Arthritis Rheum 36 144 152 1:CAS:528:DC%2BD28XhtFOiu7nJ 10.1016/j.semarthrit.2006.07.001 16949136 (Pubitemid 44691884)
5. AA Fitzgerald SA Leclercq A Yan, et al. 2005 Rapid responses to anakinra in patients with refractory adult-onset Still's disease Arthritis Rheum 52 1794 1803 1:CAS:528:DC%2BD2MXlvFChurs%3D 10.1002/art.21061 15934079 (Pubitemid 40852888)
6. V Oldfield S Dhillon GL Plosker 2009 Tocilizumab: a review of its use in the management of rheumatoid arthritis Drugs 69 609 632 1:CAS:528: DC%2BD1MXnsFOiu7g%3D 10.2165/00003495-200969050-00007 19368420
7. RN Maini PC Taylor J Szechinski K Pavelka J Broll G Balint P Emery F Raemen J Petersen J Smolen D Thomson T Kishimoto 2006 Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate Arthritis Rheum 54 2817 2829 1:CAS:528:DC%2BD28XhtFWksLjK 10.1002/art.22033 16947782 (Pubitemid 44497760)
8. Y Ohsugi 2007 Recent advances in immunopathophysiology of tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases Biol Pharm Bull 30 2001 2006 1:CAS:528:DC%2BD1cXisVCntQ%3D%3D 10.1248/bpb.30.2001 17978466 (Pubitemid 350097028)
9. N Nishimoto N Miyasaka K Yamamoto S Kawai T Takeuchi J Azuma T Kishimoto 2009 Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) Mod Rheumatol 19 12 19 1:CAS:528:DC%2BD1MXhsFKmsLk%3D 10.1007/s10165-008-0125-1 18979150
10. S Yokota T Miyamae T Imagawa S Katakura R Kurosawa M Mori 2005 Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis Clin Rev Allergy Immunol 28 231 238 1:CAS:528:DC%2BD2MXhtFars7%2FJ 10.1385/CRIAI:28:3:231 16129907 (Pubitemid 41208912)
11. S Yokota T Miyamae T Imagawa N Iwata S Katakura M Mori P Woo N Nishimoto K Yoshizaki T Kishimoto 2005 Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis Arthritis Rheum 52 818 825 1:CAS:528:DC%2BD2MXjtVGjtLg%3D 10.1002/art.20944 15751095 (Pubitemid 40365104)
12. Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998-1006. (Pubitemid 351389534)
13. N Nishimoto K Terao T Mima H Nakahara N Takagi T Kakehi 2008 Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with RA and Castleman Blood 112 3959 3964 1:CAS:528:DC%2BD1cXhsVSmsrzJ 10.1182/blood-2008-05-155846 18784373
14. H Nakamura T Mima N Yoshio-Hoshino M Matsushita J Hashimoto N Nishimoto 2009 A case report of a patient with refractory adult-onset Still's disease who was successfully treated with tocilizumab over 6 years Mod Rheumatol 19 69 72 10.1007/s10165-009-0167-z
15. K Matsumoto T Nagashima S Takatori Y Kawahara M Yagi M Iwamoto H Okazaki S Minota 2009 Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab Clin Rheumatol 28 485 487 10.1007/s10067-009-1097-z 19184270
16. M De Bandt B Saint-Marcoux 2009 TCZ for multirefractory AOSD Ann Rheum Dis 68 153 154 10.1136/ard.2008.088179 19088261
17. Behrens EM. MAS in rheumatic disease. What is the role of the antigen presenting cell? Autoimmun Rev. 2008;7:305-8.
18. M Szyper-Kravitz 2009 The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm Isr Med Assoc J 11 633 634 20077953
19. X Zhang DM Mosser 2008 Macrophage activation by endogenous danger signals J Pathol 214 161 178 1:STN:280:DC%2BD1c%2FgtlOntw%3D%3D 10.1002/path.2284 18161744 (Pubitemid 351160154)
20. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49:633-9. (Pubitemid 37296468)
21. JB Arlet TH Le A Marinho Z Amoura B Wechsler T Papo JC Piette 2006 Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature Ann Rheum Dis 65 1596 1601 10.1136/ard.2005.046904 16540551 (Pubitemid 44799671)
22. A Hot ML Toh B Coppéré L Perard MH Madoux C Mausservey H Desmurs-Clavel M Ffrench J Ninet 2010 Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients Medicine (Baltimore) 89 37 46 10.1097/MD.0b013e3181caf100
23. M Amenomori K Migita T Miyashita S Yoshida M Ito K Eguchi H Ezaki 2005 Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease Clin Exp Rheumatol 23 100 102 1:STN:280:DC%2BD2M7lslWlug%3D%3D 15789896 (Pubitemid 40424767)
24. S Sawhney P Woo KJ Murray 2001 Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders Arch Dis Child 85 421 426 1:STN:280:DC%2BD3MrmsV2ktg%3D%3D 10.1136/adc.85.5.421 11668110 (Pubitemid 33702300)
25. JL Stéphan I Koné-Paut C Galambrun R Mouy B Bader-Meunier AM Prieur 2001 Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients Rheumatology 40 1285 1292 10.1093/rheumatology/40.11.1285 11709613
26. M Mitamura Y Tada S Koarada H Inoue R Suematsu A Ohta K Nagasawa 2009 Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease Mod Rheumatol 19 57 63 1:CAS:528:DC%2BD1MXhsFKmsLc%3D 10.1007/s10165-008-0126-0 18839270
27. B Fautrel C Borget S Rozenberg O Meyer X Le Loët C Masson AC Koeger MF Kahn P Bourgeois 1999 Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease J Rheumatol 26 373 378 1:CAS:528: DyaK1MXht1yjt7Y%3D 9972972 (Pubitemid 29066742)
28. Beresford MW, Baildam EM. New advances in the management of juvenile idiopathic arthritis. 2: The era of biologicals. Arch Dis Child Educ Pract Ed. 2009;94:151-6.
29. V Gerloni I Pontikaki M Gattinara F Fantini 2008 Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients Ann Rheum Dis 67 1145 1152 1:STN:280:DC%2BD1cvksVWmtQ%3D%3D 10.1136/ard.2007.069484 17981916
30. Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch National Register. Ann Rheum Dis. 2009;68:635-41.
31. CE Pain LJ McCann 2009 Challenges in the management of juvenile idiopathic arthritis with etanercept Biologics 3 127 139 1:CAS:528: DC%2BD1MXmsFSmtL0%3D 19707402
32. T Babacan AM Onat Y Pehlivan G Comez M Karakök 2010 Successful treatment of refractory adult Still's disease and membranous glomerulonephritis with infliximab Clin Rheumatol 29 423 426 10.1007/s10067-009-1331-8 20101429
33. S Gianella DJ Schaer U Schwarz M Kurrer FL Heppner J Fehr JD Seebach 2008 Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome Am J Hematol 83 424 427 10.1002/ajh.21084 18183612 (Pubitemid 351614760)
34. A Stern R Riley L Buckley 2001 Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy J Clin Rheumatol 7 252 256 1:STN:280:DC%2BD2svgtVyltA%3D%3D 10.1097/00124743-200108000-00013 17039144 (Pubitemid 32772086)
35. E Cortis A Insalaco 2006 Macrophage activation syndrome in juvenile idiopathic arthritis Acta Paediatr Suppl 95 38 41 10.1080/08035320600649713 16801165 (Pubitemid 43995537)